Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,

Education 59

Education Kidney Disease Diabetes Cardiovascular Disease 59

Cardiometabolic Health Congress

AUGUST 23, 2024

Our expert faculty at CMHC delve into critical issues, offering insights on managing very low LDL-C, addressing concerns with statins and new-onset diabetes, and exploring the residual ASCVD risk beyond LDL-C, among other essential topics, in the CMHC Lipid Management Hub.

Dementia 52

Dementia Cholesterol Risk Factors CME 52

DAIC

MARCH 8, 2024

mg or placebo to cardiovascular standard of care in adults with overweight and obesity with established CVD and without diabetes. 1 The most common adverse event leading to discontinuation was gastrointestinal disorders, occurring in 10% of patients in the Wegovy group and 2% in the placebo group. 2 Wegovy 2.4 with placebo.

Obesity 111

Obesity Heart Disease Heart Attack Heart attacks 111